| Bioactivity | 2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2,6-Dichloro-2',3',5'-triacetyl-purine riboside |
| CAS | 3056-18-6 |
| Formula | C15H14Cl2N4O7 |
| Molar Mass | 433.20 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2,6-Dichloro-2',3',5'-triacetyl-purine riboside
CAS: 3056-18-6 F: C15H14Cl2N4O7 W: 433.20
2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a purine nucleoside analog. Purine nucleoside analogs have broad anti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.